These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38351535)

  • 1. miRNA-449c-5p regulates the JAK-STAT pathway in inhibiting cell proliferation and invasion in human breast cancer cells by targeting ERBB2.
    Li L; Zhang Y; Yang K; Liu W; Zhou Z; Xu Y
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1974. PubMed ID: 38351535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression.
    Shan X; Wen W; Zhu D; Yan T; Cheng W; Huang Z; Zhang L; Zhang H; Wang T; Zhu W; Zhu Y; Zhu J
    PLoS One; 2017; 12(1):e0170298. PubMed ID: 28099468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-223-5p Suppresses OTX1 to Mediate Malignant Progression of Lung Squamous Cell Carcinoma Cells.
    Lu Y
    Comput Math Methods Med; 2021; 2021():6248793. PubMed ID: 34306176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway.
    Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X
    Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-383-5p acts as a potential prognostic biomarker and an inhibitor of tumor cell proliferation, migration, and invasion in breast cancer.
    Zhang J; Kong X; Shi Q; Zhao B
    Cancer Biomark; 2020; 27(4):423-432. PubMed ID: 31903982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-379-5p inhibits the proliferation, migration, and invasion of breast cancer by targeting KIF4A.
    Yang K; Li D; Jia W; Song Y; Sun N; Wang J; Li H; Yin C
    Thorac Cancer; 2022 Jul; 13(13):1916-1924. PubMed ID: 35608059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-449c-5p inhibits osteogenic differentiation of human VICs through Smad4-mediated pathway.
    Xu R; Zhao M; Yang Y; Huang Z; Shi C; Hou X; Zhao Y; Chen B; Xiao Z; Liu J; Miao Q; Dai J
    Sci Rep; 2017 Aug; 7(1):8740. PubMed ID: 28821833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-424-5p regulates cell proliferation, migration and invasion by targeting doublecortin-like kinase 1 in basal-like breast cancer.
    Wang J; Wang S; Zhou J; Qian Q
    Biomed Pharmacother; 2018 Jun; 102():147-152. PubMed ID: 29550638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.
    Sui MH; Zhang WW; Geng DM; Sun DJ
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-449c-5p alleviates lipopolysaccharide-induced HUVECs injury via inhibiting the activation NF-κb signaling pathway by TAK1.
    Fu Q; Yu W; Fu S; Xu Z; Zhang S
    Mol Immunol; 2022 Jun; 146():18-26. PubMed ID: 35421737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-485-5p inhibits the progression of breast cancer cells by negatively regulating MUC1.
    Wang X; Zhou X; Zeng F; Wu X; Li H
    Breast Cancer; 2020 Jul; 27(4):765-775. PubMed ID: 32144736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-198 affects the proliferation and apoptosis of colorectal cancer through regulation of ADAM28/JAK-STAT signaling pathway.
    Li LX; Lam IH; Liang FF; Yi SP; Ye LF; Wang JT; Guo WW; Xu M
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1487-1493. PubMed ID: 30840270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA LINC00662 promotes proliferation and migration of breast cancer cells via regulating the miR-497-5p/EglN2 axis.
    Cheng L; Xing Z; Zhang P; Xu W
    Acta Biochim Pol; 2020 Jun; 67(2):229-237. PubMed ID: 32558530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA DANCR promoted non-small cell lung cancer cells metastasis via modulating of miR-1225-3p/ErbB2 signal.
    Huang YF; Zhang Y; Fu X
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):758-769. PubMed ID: 33577030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX2 regulates multiple malignant processes of breast cancer development through the SOX2/miR-181a-5p, miR-30e-5p/TUSC3 axis.
    Liu K; Xie F; Gao A; Zhang R; Zhang L; Xiao Z; Hu Q; Huang W; Huang Q; Lin B; Zhu J; Wang H; Que J; Lan X
    Mol Cancer; 2017 Mar; 16(1):62. PubMed ID: 28288641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA circ-ERBB2 promotes HER2-positive breast cancer progression and metastasis via sponging miR-136-5p and miR-198.
    Zhong JX; Kong YY; Luo RG; Xia GJ; He WX; Chen XZ; Tan WW; Chen QJ; Huang YY; Guan YX
    J Transl Med; 2021 Nov; 19(1):455. PubMed ID: 34732216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of exosomal miR-7-5p promotes breast cancer migration and invasion by targeting RYK and participating in the atypical WNT signalling pathway.
    Liang Z; Liu L; Gao R; Che C; Yang G
    Cell Mol Biol Lett; 2022 Oct; 27(1):88. PubMed ID: 36210461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA TMPO-AS1 facilitates the proliferation and metastasis of NSCLC cells by up-regulating ERBB2 via sponging miR-204-3p.
    Yu X; Lin Q; Liu F; Yang F; Mao J; Chen X
    Int J Immunopathol Pharmacol; 2020; 34():2058738420958947. PubMed ID: 32969763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CircRNA NRIP1 promotes papillary thyroid carcinoma progression by sponging mir-195-5p and modulating the P38 MAPK and JAK/STAT pathways.
    Li C; Zhu L; Fu L; Han M; Li Y; Meng Z; Qiu X
    Diagn Pathol; 2021 Oct; 16(1):93. PubMed ID: 34689819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.